Exosomes to protect the brain in very premature babies
Part of Brain & nervous system, Heart & circulation, Mental health, Women’s health & pregnancy clinical trials.
This trial studies whether a treatment made from tiny cell packets (exosomes) can help protect the brain in extremely low birth weight, very premature newborns. It’s meant to test whether the approach is safe and may reduce brain-related harm from prematurity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby must be born very early, at 25 weeks 0 days to 27 weeks 6 days of pregnancy
- You must be able to provide written parental consent
- Baby must not have serious birth defects or genetic/chromosome conditions
- Baby must not have a serious facial/nose problem (like major nasal injury or major jaw/face defects)
- Baby must be alive and expected to receive active intensive care for the study period
- Baby should not be in a different study using an unapproved treatment during the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving special beneficial bacteria (probiotics) to premature babies who received antibiotics in the hospital can help their brain and nervous system develop better. Researchers will follow your baby for 6 months to see if probiotics improve development.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This trial tests whether a type of stem cell (mesenchymal stromal cells) can help prevent bronchopulmonary dysplasia, a serious lung condition, in very premature babies. Babies born before 28 weeks who are on a breathing machine with high oxygen needs may be eligible.
This trial tests a new drug made from stem cell exosomes (CB-Exo-A600) to see if it can help people with mild to moderate Alzheimer's disease. It aims to slow down symptoms and improve quality of life.
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
This trial tests if stem cells can help premature babies with severe lung disease (bronchopulmonary dysplasia). It is for very small, early-born babies who still need a breathing machine between 5 and 14 days after birth.
Hear when a new Premature Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.